You are here

executives

Bausch + Lomb ‘reshaping’ executive team

Bausch + Lomb ‘reshaping’ executive team

NJ Biz

Flag link:

Eli Lilly signs CSO Daniel Skovronsky to $5M non-compete clause

Eli Lilly signs CSO Daniel Skovronsky to $5M non-compete clause

Medical Marketing and Media

Daniel Skovronsky

Flag link:

AstraZeneca draws back the curtains on its leadership team, launches new podcast

AstraZeneca draws back the curtains on its leadership team, launches new podcast

Fierce Pharma

Flag link:

Magenta's C-suite heads out the door with 85% of staff as closing process gets underway

Magenta's C-suite heads out the door with 85% of staff as closing process gets underway

Fierce Biotech

Magenta Therapeutics

Flag link:

JPM23 squawk box: What’s changing – and what isn’t – at big healthcare companies

JPM23 squawk box: What’s changing – and what isn’t – at big healthcare companies

Medical Marketing and Media

Flag link:

Biopharma Executive Perspectives on 2023

Biopharma Executive Perspectives on 2023

BioSpace

Flag link:

Medtech execs ‘rethink’ long-term strategies as care settings shift: Accenture report

Medtech execs ‘rethink’ long-term strategies as care settings shift: Accenture report

Medtech Dive

ambulatory care

Flag link:

'Beginning of a broader loss': Pharma execs call regulators and legislators to action four months post-Roe

'Beginning of a broader loss': Pharma execs call regulators and legislators to action four months post-Roe

Endpoints

Female Executives

reproductive rights

Flag link:

AstraZeneca scores injunction to temporarily halt former exec's start at crosstown rival GSK

AstraZeneca scores injunction to temporarily halt former exec's start at crosstown rival GSK

Fierce Pharma

Flag link:

AstraZeneca heads to court to contest former exec's move to crosstown rival GSK: report

AstraZeneca heads to court to contest former exec's move to crosstown rival GSK: report

Fierce Pharma

Flag link:

‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar

‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar

BioSpace

Flag link:

J&J science chief Stoffels to retire after decade at the top, adding to C-suite changes

J&J science chief Stoffels to retire after decade at the top, adding to C-suite changes

Fierce Biotech

Flag link:

Exelixis stunned by death of Chief Medical Officer Schwab, sales lead Berndt

Exelixis stunned by death of Chief Medical Officer Schwab, sales lead Berndt

Fierce Biotech

Flag link:

Women's History Month: Top Influential Women in Biopharma

Women's History Month: Top Influential Women in Biopharma

BioSpace

Flag link:

Pfizer shakes up the top team that will now lead the pharma giant under Albert Bourla

Pfizer shakes up the top team that will now lead the pharma giant under Albert Bourla

Endpoints

Flag link:

Biotech’s Looming Talent Crisis: 5 Ways to Prepare for the Storm

Biotech’s Looming Talent Crisis: 5 Ways to Prepare for the Storm

Xconomy

human resources

Flag link:

Grey Hair In the C-Suite: Experience, Age, And IPOs In Biotech

Grey Hair In the C-Suite: Experience, Age, And IPOs In Biotech

Forbes

Flag link:

Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul

Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul

Endpoints

Teva Pharmaceutical

Flag link:

Eli Lilly Announces Management Changes

Eli Lilly Announces Management Changes

TheStreet.com

Flag link:

Activis to Replace Most Allergan Executives After Deal

Activis to Replace Most Allergan Executives After Deal

Bloomberg

Flag link: